NIH: Weight gain does not outweigh smoking cessation in risk of CVD
BETHESDA, Md. — The improvement in cardiovascular health that results from quitting smoking far outweighs the limited risks to cardiovascular health from the modest amount of weight gained after quitting, according to a National Institutes of Health-funded community study released Wednesday.
“Our findings suggest that a modest weight gain, around 5-10 pounds, has a negligible effect on the net benefit of quitting smoking,” stated study co-author Caroline Fox, senior investigator in the Laboratory for Metabolic and Population Health at the NIH’s National Heart, Lung, and Blood Institute. “Being able to quantify to some degree the relationship between the benefits and side effects of smoking cessation can help in counseling those who have quit or are thinking about quitting.”
The study found that former smokers without diabetes had about half as much risk of developing cardiovascular disease as current smokers, and this risk level did not change when post-cessation weight gain was accounted for in the analysis. Fox cautioned that the analysis could not definitively conclude the role of modest weight gain in former smokers with diabetes, though the numbers suggested a similar trend.
This study is the first epidemiological effort to directly address the health impact of the weight gain that many people experience following smoking cessation. The findings will be published in the March 13 Journal of the American Medical Association.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
Walgreens, Bausch + Lomb partner on web-based patient education program on eye health
ROCHESTER, N.Y. — Bausch + Lomb and Walgreens on Wednesday introduced a new SightSense online and in-store patient education program in an effort to heighten eye health awareness and encourage consumers to take proactive steps to protect and preserve their sight.
“We know that more than 80% of visual impairment is preventable, which makes it that much more important to elevate eye health awareness among consumers," stated Calvin Roberts, Bausch + Lomb EVP and chief medical officer. "Through the SightSense program we have an opportunity to do just that, and ultimately help people preserve and protect their most treasured sense, as well as improve their overall health.”
The SightSense program features a special eye health section on Walgreens.com that provides tools, information and resources to help consumers become informed and proactive in their eye health, including a PSA-like video that illustrates the connection between eye health and overall wellness, as well as an eye health assessment test to screen for common problems. The web site also provides an eye care professional locator for consumers to find an eye doctor near them, as well as a list of upcoming in-store events.
SightSense in-store events will be held in approximately 10 cities across the country in 2013, including Chicago, Los Angeles and Miami. The events will feature educational forums led by eye health professionals as well as eye screenings for common problems. Additionally, informative brochures on eye health will be available at all Walgreens stores nationwide beginning in July 2013.
Through both the online and in-store components of the SightSense program, consumers will be encouraged to get regular eye exams from their local eye care professionals, a key step to maintaining healthy eyes and preventing other health-related issues.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.
Robin Leedy and Associates wins three new OTC clients
MOUNT KISCO, N.Y. — Public relations and digital marketing firm Robin Leedy and Associates has added three new clients, the firm said Tuesday.
RL&A said the clients were Matrixx Initiatives, which makes the Zicam family of pre-cold and nasal congestion products; Crosscare, which makes Colief Infant Drops for colic related to transient lactase deficiency; and Cirrus Healthcare Products, which makes EarPlanes air-pressure ear plugs, as well as AquaEars for children. The firm specializes in OTC, health and beauty aids and consumer lifestyle brands marketed to women.
"We’ve been developing social media and digital marketing initiatives for clients, particularly in the OTC and HBA space, that balance motivating messages and innovative, integrated platforms with [the Food and Drug Administration] and other regulatory requirements and brand marketing goals," RL&A president Robin Russo said.